Market Capitalization

Extreme Connect 2026 showcases an AI-first strategy to challenge industry giants, promising a new era of automated, intelligent enterprise networks.

Soluna Holdings is aggressively expanding from Bitcoin to AI, betting its future on turning wasted renewable energy into high-demand computing power.

A new survey finds companies are dynamically adjusting investment hurdles in response to market chaos, leveraging technology to navigate an uncertain world.

With its finances on a knife's edge, Faraday Future is pitching a bold new vision of AI robots and mass-market EVs to skeptical investors. Can it deliver?

Hallador Energy appoints M&A veteran Daniel Hudson to its board and promotes Heath Lovell to COO, signaling a major push to expand its power platform.

The parent of Meineke and Maaco admits to 'material errors' in its financials, triggering a massive stock sell-off and a wave of investor lawsuits.

Underdog acquires a federally regulated exchange, moving from intermediary to operator. This bold move could reshape the entire sports prediction market.

Burford Capital's leadership invests millions from their own pay, claiming shares are deeply discounted. But will the market agree with their bold move?

As electroCore preps its 2025 financial report, all eyes are on its product growth, the new Quell device, and its path to profitability in the booming bioelectronic market.

With record backlogs and surging demand from AI and energy transition, Quanta's March 31st event will reveal new targets shaping the future of infrastructure.

Brookfield Real Assets Income Fund announces a key manager departure, signaling a deeper integration with its vast institutional resources for investors.

Diana Shipping escalates its takeover attempt of Genco with a higher, fully financed offer, setting the stage for a dramatic corporate showdown.

A new report reveals a puzzling slowdown in CLO issuance despite low credit yields. Experts analyze the hidden headwinds and shifting investor strategies.

With $336M in the bank and three autoimmune drugs advancing, Jade Biosciences lays out a fast-paced timeline for key clinical milestones in 2026 and 2027.

The toy giant's new $400M debt offering isn't just about paying bills; it's a strategic move to extend its financial runway and invest in its future.

BioRestorative Therapies is leveraging its clinical-grade regenerative medicine to disrupt the aesthetics industry. Can science beat marketing?

German defense tech firm RENK Group reports a record €1.37B revenue, fueled by a 24% surge in its defense business amid global geopolitical tensions.

Backed by Nobel-winning science and French state support, Pasqal's move to go public validates the commercial promise of deep quantum technology.

Hamilton Global Opportunities will spotlight the trend of retail access to private equity at an upcoming investor event, highlighting its role as a gateway.

After a 1-for-12 reverse stock split saved it from delisting, Cre8 Enterprise must now prove its strategic pivot is more than a temporary fix.